CIDeRplusGeneral Information:
| Id: | 3,388 (click here to show other Interactions for entry) |
| Diseases: |
Cardiovascular disease
Carnitine deficiency, systemic primary - [OMIM] Diabetes mellitus, type II - [OMIM] Insulin resistance Status epilepticus |
| Mammalia | |
| review | |
| Reference: | Ringseis R et al.(2012) Role of carnitine in the regulation of glucose homeostasis and insulin sensitivity: evidence from in vivo and in vitro studies with carnitine supplementation and carnitine deficiency Eur J Nutr 1: 1-18 [PMID: 22134503] |
Interaction Information:
| Comment | In humans, secondary carnitine deficiency is observed during treatment with valproic acid, a broad-spectrum anti-epileptic drug that is now used commonly for several other neurological and psychiatric indications. |
|
Formal Description Interaction-ID: 31813 |
|
| Drugbank entries | Show/Hide entries for Valproic acid |